Institute for Medical Science and Brain Korea 21 Program, Ajou University School of Medicine, Suwon 443-721, Republic of Korea.
Mol Immunol. 2013 Jul;54(3-4):338-46. doi: 10.1016/j.molimm.2012.12.013. Epub 2013 Jan 26.
Heat shock protein 60 (HSP60) is an important autoantigen in atherosclerosis. The genetic structures and pathogenic roles of anti-HSP60 autoantibodies, however, have not been well elucidated. Here, we cloned nine monoclonal IgG Fabs against human HSP60 from peripheral blood lymphocytes of atherosclerosis patients. Analysis of the variable region sequences revealed that the antibodies used diverse members of V(H) gene families with different D(H) and J(H) segments. However, in V(L), KV3-20 gene family member along with KJ1 segment was used often. Similarities between the rearranged genes and the closest germline sequences were low. The sequences of V(H) were highly mutated and V(H)-CDR3 varied greatly in length and sequences. The ratios of R/S (replacement mutation to silent mutation) were remarkably high in CDRs in all V(H) regions except one clone. Furthermore, mutations to positively charged amino acids were frequent in all V(H) and most V(L). These results suggest that the occurrence of somatic hypermutation and antigenic selection is critical, not the usage of certain V(H) gene family members or segments, in producing affinity-matured anti-HSP60 autoantibodies in atherosclerosis. However, expression of the combined germline genes of KV3-20 with KJ1 might be important for the selection by HSP60 at the early stage of B cell development. Two of these anti-HSP60 Fabs inhibited the binding and uptake of human HSP60 by murine macrophage cells. One of them also reduced the release of the pro-inflammatory mediators and inhibited the activation of NF-κB in HSP60-stimulated macrophages. To elucidate the functional roles of anti-HSP60 autoantibodies in atherosclerosis and the potential use of these Fabs to treat atherosclerosis, further investigation is worthy to be performed.
热休克蛋白 60(HSP60)是动脉粥样硬化中的一种重要自身抗原。然而,抗 HSP60 自身抗体的遗传结构和致病作用尚未得到很好的阐明。在这里,我们从动脉粥样硬化患者的外周血淋巴细胞中克隆了 9 种针对人 HSP60 的单克隆 IgG Fabs。可变区序列分析表明,所使用的抗体多样化地利用了不同的 V(H)基因家族成员,具有不同的 D(H)和 J(H)片段。然而,在 V(L)中,经常使用 KV3-20 基因家族成员和 KJ1 片段。重排基因与最接近的种系序列之间的相似性较低。V(H)的序列高度突变,V(H)-CDR3 的长度和序列变化很大。除了一个克隆外,所有 V(H)区域的 CDR 中的 R/S(替换突变对沉默突变)比率都非常高。此外,所有 V(H)和大多数 V(L)中都频繁出现正电荷氨基酸的突变。这些结果表明,在动脉粥样硬化中产生亲和力成熟的抗 HSP60 自身抗体,发生体细胞超突变和抗原选择是至关重要的,而不是使用某些 V(H)基因家族成员或片段。然而,KV3-20 与 KJ1 的组合种系基因的表达对于 B 细胞发育早期 HSP60 的选择可能很重要。这些抗 HSP60 Fabs 中的两种抑制了人 HSP60 与鼠巨噬细胞的结合和摄取。其中一种还减少了 HSP60 刺激的巨噬细胞中促炎介质的释放,并抑制了 NF-κB 的激活。为了阐明抗 HSP60 自身抗体在动脉粥样硬化中的功能作用以及这些 Fab 治疗动脉粥样硬化的潜在用途,值得进一步研究。